These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33204971)

  • 1. The personalized antithrombotic management of atrial fibrillation with intermediate thromboembolic risk: a case report.
    Hammer A; Schnaubelt S; Niessner A; Sulzgruber P
    Eur Heart J Case Rep; 2020 Oct; 4(5):1-4. PubMed ID: 33204971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke.
    Sulzgruber P; Wassmann S; Semb AG; Doehner W; Widimsky P; Gremmel T; Kaski JC; Savarese G; Rosano GMC; Borghi C; Kjeldsen K; Torp-Pedersen C; Schmidt TA; Lewis BS; Drexel H; Tamargo J; Atar D; Agewall S; Niessner A
    Eur Heart J Cardiovasc Pharmacother; 2019 Jul; 5(3):171-180. PubMed ID: 31119266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stroke Risk Stratification Schemes in Atrial Fibrillation in the Era of Non- Vitamin K Anticoagulants: Misleading and Obsolete, At Least for the "Low-Risk" Patients?
    Manolis AS; Manolis TA; Manolis AA; Melita H
    Curr Drug Targets; 2017 Nov; 18(16):1852-1865. PubMed ID: 27593686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report.
    Lip GYH; Banerjee A; Boriani G; Chiang CE; Fargo R; Freedman B; Lane DA; Ruff CT; Turakhia M; Werring D; Patel S; Moores L
    Chest; 2018 Nov; 154(5):1121-1201. PubMed ID: 30144419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS
    Katz DF; Maddox TM; Turakhia M; Gehi A; O'Brien EC; Lubitz SA; Turchin A; Doros G; Lei L; Varosy P; Marzec L; Hsu JC
    Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do CHA2 DS2 VASc and HAS-BLED scores influence 'real-world' anticoagulation management in atrial fibrillation? 1556 patient registry from the reference cardiology centre.
    Lopatowska P; Tomaszuk-Kazberuk A; Mlodawska E; Bachorzewska-Gajewska H; Malyszko J; Dobrzycki S; Musial WJ
    Pharmacoepidemiol Drug Saf; 2015 Dec; 24(12):1297-303. PubMed ID: 26419506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Adherence to Guideline-Directed Antithrombotic Therapy for Atrial Fibrillation at Hospital Discharge.
    Dupree L; DeLosSantos M; Smotherman C
    J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):502-508. PubMed ID: 29806486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; de Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B
    Thromb Haemost; 2017 Dec; 117(12):2215-2236. PubMed ID: 29212110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stroke risk reduction with oral anticoagulation using CHA2DS2-VASc in a Japanese AF population: A modeling analysis.
    Senoo K; Lane DA; Lip GY
    Int J Cardiol; 2015 Feb; 181():247-54. PubMed ID: 25528530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Oliveira MM; Mairesse G; Crijns HJ; Simantirakis E; Atar D; Kirchhof P; Vardas P; Tavazzi L; Maggioni AP
    Europace; 2014 Mar; 16(3):308-19. PubMed ID: 24351881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of CHADS2 and CHA2DS2-VASC anticoagulation recommendations: evaluation in a cohort of atrial fibrillation ablation patients.
    Winkle RA; Mead RH; Engel G; Kong MH; Patrawala RA
    Europace; 2014 Feb; 16(2):195-201. PubMed ID: 24036378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation in "real world" patients with atrial fibrillation in Italy: results from the ISPAF (Indagine Sicoa Paziente Con Fibrillazione Atriale) survey study.
    Volterrani M; Iellamo F; Rosano G; Guarini P; Pusineri E; Bonassi S; Chimini C; Zaccà F; Proto C;
    Int J Cardiol; 2013 Oct; 168(5):4729-33. PubMed ID: 23948115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA2DS2-VASc Risk Factor Be Anticoagulated?
    Fauchier L; Clementy N; Bisson A; Ivanes F; Angoulvant D; Babuty D; Lip GY
    Stroke; 2016 Jul; 47(7):1831-6. PubMed ID: 27231269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practice Gap in Atrial Fibrillation Oral Anticoagulation Prescribing at Emergency Department Home Discharge.
    Kea B; Waites BT; Lin A; Raitt M; Vinson DR; Ari N; Welle L; Sill A; Button D; Sun BC
    West J Emerg Med; 2020 Jun; 21(4):924-934. PubMed ID: 32726266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Oral Anticoagulation in a Real-World Population With Device Detected Atrial Fibrillation.
    Kaplan RM; Ziegler PD; Koehler J; Landman S; Sarkar S; Passman RS
    J Am Heart Assoc; 2020 Dec; 9(24):e018378. PubMed ID: 33252286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Korean Heart Rhythm Society's 2014 Statement on Antithrombotic Therapy for Patients with Nonvalvular Atrial Fibrillation: Korean Heart Rhythm Society.
    Jung BC; Kim NH; Nam GB; Park HW; On YK; Lee YS; Lim HE; Joung B; Cha TJ; Hwang GS; Oh S; Kim JS
    Korean Circ J; 2015 Jan; 45(1):9-19. PubMed ID: 25653698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
    Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.
    Huisman MV; Ma CS; Diener HC; Dubner SJ; Halperin JL; Rothman KJ; Teutsch C; Schoof N; Kleine E; Bartels DB; Lip GY;
    Europace; 2016 Sep; 18(9):1308-18. PubMed ID: 27335063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of the European society of cardiology guidelines for refining stroke risk stratification in patients with atrial fibrillation categorized as low risk using the anticoagulation and risk factors in atrial fibrillation stroke score: a nationwide cohort study.
    Lip GYH; Nielsen PB; Skjøth F; Lane DA; Rasmussen LH; Larsen TB
    Chest; 2014 Nov; 146(5):1337-1346. PubMed ID: 25086251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.